Macrolide‐resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?
dc.contributor.author | Eschenauer, Gregory A. | |
dc.contributor.author | Xiao, Li | |
dc.contributor.author | Waites, Ken B. | |
dc.contributor.author | Crabb, Donna M. | |
dc.contributor.author | Ratliff, Amy E. | |
dc.contributor.author | Gandhi, Tejal N. | |
dc.contributor.author | Riddell, James | |
dc.contributor.author | Kaul, Daniel R | |
dc.date.accessioned | 2020-11-04T16:02:37Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2020-11-04T16:02:37Z | |
dc.date.issued | 2020-10 | |
dc.identifier.citation | Eschenauer, Gregory A.; Xiao, Li; Waites, Ken B.; Crabb, Donna M.; Ratliff, Amy E.; Gandhi, Tejal N.; Riddell, James; Kaul, Daniel R (2020). "Macrolide‐resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?." Transplant Infectious Disease 22(5): n/a-n/a. | |
dc.identifier.issn | 1398-2273 | |
dc.identifier.issn | 1399-3062 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/163484 | |
dc.description.abstract | Mycoplasma pneumoniae is one of the most common bacterial causes of pneumonia. Macrolide‐resistant M pneumoniae (MRMP) was documented in 7.5% of isolates in the United States. Resistance portends poor outcomes to macrolide therapy, yet patients respond well to fluoroquinolones or tetracyclines such as minocycline. However, MRMP may be under‐appreciated because M pneumoniae generally causes relatively mild infections in non‐immunosuppressed adults that may resolve without effective therapy and because microbiological confirmation and susceptibility are not routinely performed. We report two cases of pneumonia due to MRMP in kidney transplant recipients. Both patients required hospital admission, worsened on macrolide therapy, and rapidly defervesced on doxycycline or levofloxacin. In one case, M pneumoniae was only identified by multiplex respiratory pathogen panel analysis of BAL fluid. Macrolide resistance was confirmed in both cases by real‐time PCR and point mutations associated with macrolide resistance were identified. M pneumoniae was isolated from both cases, and molecular genotyping revealed the same genotype. In conclusion, clinicians should be aware of the potential for macrolide resistance in M pneumoniae, and may consider non‐macrolide‐based therapy for confirmed or non‐responding infections in patients who are immunocompromised or hospitalized. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | ASM Press | |
dc.subject.other | transplantation | |
dc.subject.other | Mycoplasma pneumoniae | |
dc.subject.other | resistance | |
dc.subject.other | resistant | |
dc.subject.other | macrolide | |
dc.title | Macrolide‐resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical? | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163484/2/tid13318.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163484/1/tid13318_am.pdf | en_US |
dc.identifier.doi | 10.1111/tid.13318 | |
dc.identifier.source | Transplant Infectious Disease | |
dc.identifier.citedreference | Miyashita N, Akaike H, Teranishi H, et al. Macrolide‐resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrob Agents Chemother. 2013; 57: 5181 ‐ 5185. | |
dc.identifier.citedreference | Waites KB, Xiao L, Liu Y, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017; 30: 747 ‐ 809. | |
dc.identifier.citedreference | Tashiro M, Fushimi K, Kawano K, et al. Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumonia pneumonia in Japan during large epidemics of macrolide‐resistant M pneumoniae infections: a nationwide observational study. Clin Infect Dis. 2017; 65: 1837 ‐ 1842. | |
dc.identifier.citedreference | Sun H, Xue G, Yan C, et al. Multiple‐locus variable‐number tandem‐repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS ONE. 2013; 8: e64607. | |
dc.identifier.citedreference | Dumke R, Luck PC, Noppen C, et al. Culture‐independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol. 2006; 44: 2567 ‐ 2570. | |
dc.identifier.citedreference | Sasaki T, Kenri T, Okazaki N, et al. Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR‐restriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol. 1996; 34: 447 ‐ 449. | |
dc.identifier.citedreference | Waites KB, Duffy LB, Xiao L. Detection of human mycoplasmas and ureaplasmas from clinical specimens by culture and PCR. In: Laber A ed. Clinical Microbiology Procedure Handbook, ( 4th ed. ). Washington, DC: ASM Press. Chapter 3.15, 2016. | |
dc.identifier.citedreference | Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009; 28: 693 ‐ 696. | |
dc.identifier.citedreference | Xiao L, Atkinson TP, Hagood JA, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates with real‐time PCR. Pediatric Infectious Disease Journal. 2009; 28: 693 ‐ 698. | |
dc.identifier.citedreference | Waites KB, Ratliff A, Crabb DM, et al. Macrolide‐resistant Mycoplasma pneumoniae in the United States as determined from a national surveillance program. J Clin Microbiol. 2019; 57: e00968 ‐ e1019. | |
dc.identifier.citedreference | Xiao L, Ratliff A, Crabb D, et al. Molecular characterization of Mycoplasma pneumoniae isolates in the United States from 2012‐2018. J Clin Microbiol. 2020 (in press). | |
dc.identifier.citedreference | Kawai Y, Miyashita N, Kubo M, et al. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide‐Resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother. 2013; 57: 2252 ‐ 2258. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.